Additionally, the 36-month beta value for CORZ is 5.80. There are mixed opinions on the stock, with 11 analysts rating it as a “buy,” 4 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for CORZ is 257.02M and currently, short sellers hold a 16.53% ratio of that float. The average trading volume of CORZ on March 17, 2025 was 13.68M shares.
CORZ) stock’s latest price update
Core Scientific Inc (NASDAQ: CORZ)’s stock price has soared by 1.73 in relation to previous closing price of 8.66. Nevertheless, the company has seen a gain of 13.24% in its stock price over the last five trading days. seekingalpha.com reported 2025-03-09 that Core Scientific shares are undervalued due to market volatility and false rumors about Microsoft canceling leases with CoreWeave, presenting a significant investment opportunity. CORZ has $10.2B in future contracted revenue with high margins and management expects critical IT load to more than double by 2028. Positive developments include issuing $1B in convertible notes, completing significant contracts, and insider buying, indicating confidence in the company’s future.
CORZ’s Market Performance
Core Scientific Inc (CORZ) has experienced a 13.24% rise in stock performance for the past week, with a -27.13% drop in the past month, and a -44.17% drop in the past quarter. The volatility ratio for the week is 10.88%, and the volatility levels for the past 30 days are at 10.11% for CORZ. The simple moving average for the past 20 days is -11.50% for CORZ’s stock, with a -26.13% simple moving average for the past 200 days.
Analysts’ Opinion of CORZ
Many brokerage firms have already submitted their reports for CORZ stocks, with Keefe Bruyette repeating the rating for CORZ by listing it as a “Outperform.” The predicted price for CORZ in the upcoming period, according to Keefe Bruyette is $22 based on the research report published on January 27, 2025 of the current year 2025.
Craig Hallum, on the other hand, stated in their research note that they expect to see CORZ reach a price target of $24. The rating they have provided for CORZ stocks is “Buy” according to the report published on January 21st, 2025.
ROTH MKM gave a rating of “Buy” to CORZ, setting the target price at $25.50 in the report published on November 15th of the previous year.
CORZ Trading at -27.33% from the 50-Day Moving Average
After a stumble in the market that brought CORZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -52.71% of loss for the given period.
Volatility was left at 10.11%, however, over the last 30 days, the volatility rate increased by 10.88%, as shares sank -29.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -36.53% lower at present.
During the last 5 trading sessions, CORZ rose by +13.24%, which changed the moving average for the period of 200-days by +82.78% in comparison to the 20-day moving average, which settled at $9.95. In addition, Core Scientific Inc saw -37.30% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CORZ starting from Weiss Eric Stanton, who purchase 6,000 shares at the price of $8.46 back on Mar 06 ’25. After this action, Weiss Eric Stanton now owns 221,687 shares of Core Scientific Inc, valued at $50,750 using the latest closing price.
Levy Jordan, the Director of Core Scientific Inc, purchase 62,500 shares at $8.01 during a trade that took place back on Mar 06 ’25, which means that Levy Jordan is holding 306,887 shares at $500,506 based on the most recent closing price.
Stock Fundamentals for CORZ
Current profitability levels for the company are sitting at:
- -0.03 for the present operating margin
- 0.24 for the gross margin
The net margin for Core Scientific Inc stands at -2.58. The total capital return value is set at -0.01.
Based on Core Scientific Inc (CORZ), the company’s capital structure generated 3.16 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at -1.46. The interest coverage ratio of the stock is -0.58.
Currently, EBITDA for the company is -1.16 billion with net debt to EBITDA at -0.31. When we switch over and look at the enterprise to sales, we see a ratio of 5.79. The receivables turnover for the company is 498.22for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.72.
Conclusion
In conclusion, Core Scientific Inc (CORZ) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
